264 related articles for article (PubMed ID: 11419575)
1. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
Sommer BR
J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
[TBL] [Abstract][Full Text] [Related]
2. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease.
Prueter C; Habermeyer B; Norra C; Kosinski CM
Mov Disord; 2003 Jun; 18(6):712-3. PubMed ID: 12784279
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
Parsa MA; Bastani B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
[TBL] [Abstract][Full Text] [Related]
4. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
[TBL] [Abstract][Full Text] [Related]
5. A study of quetiapine: efficacy and tolerability in psychotic adolescents.
Shaw JA; Lewis JE; Pascal S; Sharma RK; Rodriguez RA; Guillen R; Pupo-Guillen M
J Child Adolesc Psychopharmacol; 2001; 11(4):415-24. PubMed ID: 11838824
[TBL] [Abstract][Full Text] [Related]
6. Acute akathisia associated with quetiapine use.
Catalano G; Grace JW; Catalano MC; Morales MJ; Cruse LM
Psychosomatics; 2005; 46(4):291-301. PubMed ID: 16000672
[TBL] [Abstract][Full Text] [Related]
7. New Rx for psychoses in Alzheimer's, Parkinson's.
Targum SD
Contemp Longterm Care; 2001 Jan; 24(1):39-40. PubMed ID: 11209286
[No Abstract] [Full Text] [Related]
8. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
Weintraub D; Hurtig HI
Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH
Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
Stephani C; Trenkwalder C
Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
[No Abstract] [Full Text] [Related]
11. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
12. The neurochemical mechanism of rebound psychosis in Parkinson's disease.
Papapetropoulos S; Mash DC
Mov Disord; 2005 Apr; 20(4):515. PubMed ID: 15747367
[No Abstract] [Full Text] [Related]
13. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R; Cummings J; Raman R; Thal L;
Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
McManus DQ; Arvanitis LA; Kowalcyk BB
J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
Menza MM; Palermo B; Mark M
Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
[TBL] [Abstract][Full Text] [Related]
16. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
[TBL] [Abstract][Full Text] [Related]
18. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
Kohmoto J; Kihira T; Miwa H; Kondo T
No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
[TBL] [Abstract][Full Text] [Related]
19. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
Fernandez HH; Trieschmann ME; Okun MS
Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
[TBL] [Abstract][Full Text] [Related]
20. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
Giménez-Roldán S; Navarro E; Mateo D
Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
